Treatment target for diabetes, Wolfram syndrome

August 7, 2012 in Inflammatory disorders

Treatment target for diabetes, Wolfram syndrome

Enlarge

The bright green spots are TXNIP molecules, potential treatment targets for diabetes and Wolfram syndrome. Credit: Urano lab

Inflammation and cell stress play important roles in the death of insulin-secreting cells and are major factors in diabetes. Cell stress also plays a role in Wolfram syndrome, a rare, genetic disorder that afflicts children with many symptoms, including juvenile-onset diabetes.

Now a molecule has been identified that's key to the cell stress-modulated that causes insulin cells to die, report scientists at Washington University School of Medicine in St. Louis, the University of Massachusetts Medical School in Worcester and elsewhere.

"There are two types of inflammation," says senior investigator Fumihiko Urano, MD, PhD. "There is local inflammation within cells that can be caused by a specific type of cell stress named . There's also systemic inflammation that involves the activation of . The molecule we've identified is involved in the initiation of local inflammation that can lead to ."

That molecule, called thioredoxin-interacting protein (TXNIP), provides scientists with a target to direct therapies for diabetes and Wolfram syndrome. The latter disorder causes kidney problems as well as hearing and . As patients get older, they develop ataxia, a that causes a loss of and coordination, and many patients die before their 40th birthday.

The new study is published Aug. 8 in the journal .

This video is not supported by your browser at this time.

Wolfram syndrome is a rare disorder that causes insulin-dependent diabetes, kidney problems and vision and hearing loss, among other things. Now researchers at Washington University School of Medicine in St. Louis are reporting that they’ve identified a potential treatment target for Wolfram syndrome that also might help with diabetes. Jim Dryden reports… Credit: Washington University BioMed Radio

Urano, an associate professor of medicine in Washington University's Division of Endocrinology, Metabolism and Lipid Research, studies a type of cell stress known as (ER) stress. The endoplasmic reticulum is part of a cell that's responsible for producing proteins and synthesizing cholesterol. Every cell in the body has an endoplasmic reticulum, which also is involved in transporting proteins to the parts of the cell where they are needed.

In ER stress, misfolded proteins accumulate, activating a response in the cell designed to correct the problem by making fewer proteins and eliminating the misfolded ones. But if the stress cannot be resolved, the cells self destruct.

"The endoplasmic reticulum does many important things," Urano says. "When it doesn't function properly, it can contribute to several different diseases. In the case of Wolfram syndrome and diabetes, we believe that dysfunction within insulin-secreting cells causes ER stress, which, in turn, contributes to local inflammation and cell death."

Urano's team analyzed genes that were activated in insulin-producing cells under ER stress and found that TXNIP was manufactured in large amounts in the stressed cells. Past research demonstrated that the protein was involved in inflammation, and as experiments progressed, the researchers were able to link TXNIP both to ER stress within the cell and to inflammation outside of specific populations of cells that can have an effect throughout the body.

"We found that ER stress can lead to inflammation activation through the TXNIP protein," he says. "So if we could somehow block TXNIP, we may be able to mitigate the inflammation and block the progression of diabetes and Wolfram syndrome."

Urano has found that in animal models of Wolfram syndrome, TXNIP levels are significantly increased in insulin-secreting . Meanwhile, other recent research has discovered that a common blood pressure medication called verapamil can interfere with TXNIP production, so Urano's team plans to test that drug in animals with Wolfram syndrome to learn whether it might delay the progression of the disease. Those experiments, Urano says, are under way.

The TXNIP protein provides the best available target for therapies because the only other known molecule involved in cell death under ER stress conditions is housed in the cell nucleus, he says. TXNIP, on the other hand, exists outside the nucleus and therefore may more easily interact with potential therapeutic agents.

Although this study involves the extremely rare disorder Wolfram syndrome, which affects about one in 500,000 people, Urano says the findings may be important to many other diseases because inflammation contributes to so many disorders, from heart disease to cancer.

"Local inflammation such as ER stress can't be detected by looking for inflammatory molecules in blood plasma, but it is very important in the pathogenesis of many chronic human diseases," he says. "By studying TXNIP in Wolfram syndrome, we may be able to uncover clues for treating other chronic diseases, including neurodegenerative diseases, such as Alzheimer's disease and similar illnesses that cause cognitive problems."

More information: Oslowski CM, Hara T, O'Sullivan-Murphy B, Kanekura K, Lu S, Hara M, Ishigaki S, Zhu LJ, Hayashi E, Hui ST, Greiner DL, Kaufman RJ, Bortell R, Urano F. Thioredoxin-interacting protein mediates ER stress-induced beta cell death through the initiation of the inflammasome. Cell Metabolism, vol. 16 (2), Aug. 8, 2012.

Journal reference: Cell Metabolism search and more info website

Provided by Washington University School of Medicine search and more info website

5 /5 (4 votes)  

Rank 5 /5 (4 votes)
Relevant PhysicsForums posts

More news stories

A new 'on' signal for inflammation

(Medical Xpress)—Inflammation is an important response in the body - it helps you to kill off invaders such bacteria that could cause a harmful infection. But if it's chronic or uncontrolled, inflammation can also cause ...

Inflammatory disorders created May 14, 2013 | popularity not rated yet | comments 0 | with audio podcast

New research reveals swimming beneficial for young people with asthma

New research by medical students working in the Breathe Well Centre of Research Excellence at the UTAS School of Medicine has revealed swimming has health benefits for young people with asthma, with no adverse effects on ...

Inflammatory disorders created May 10, 2013 | popularity not rated yet | comments 0

Nearly 5 million asthmatics could benefit from antifungal therapy

An estimated 4,837,000 asthmatics with allergic bronchopulmonary aspergillosis (ABPA) could benefit substantially from antifungal treatment, say researchers from The University of Manchester and the University of Toronto.

Inflammatory disorders created May 08, 2013 | popularity not rated yet | comments 0

Type 1 diabetes and heart disease linked by inflammatory protein

Type 1 (insulin-dependent) diabetes appears to increase the risk of heart disease, the leading cause of death among people with high blood sugar, partly by stimulating the production of calprotectin, a protein that sparks ...

Inflammatory disorders created May 07, 2013 | popularity 4.5 / 5 (2) | comments 0 | with audio podcast

Trial asthma drug targets lung inflammation

University of Adelaide researchers at the Royal Adelaide Hospital are involved in the world's biggest study of its kind investigating a possible new treatment for asthma.

Inflammatory disorders created May 01, 2013 | popularity not rated yet | comments 0


Researchers identify a potential new risk for sleep apnea: Asthma

Researchers at the University of Wisconsin have identified a potential new risk factor for obstructive sleep apnea: asthma. Using data from the National Institutes of Health (Heart, Lung, and Blood Institute)-funded Wisconsin ...

Study finds that sleep apnea and Alzheimer's are linked

A new study looking at sleep-disordered breathing (SDB) and markers for Alzheimer's disease (AD) risk in cerebrospinal fluid (CSF) and neuroimaging adds to the growing body of research linking the two.

Computational tool translates complex data into simplified 2-dimensional images

In their quest to learn more about the variability of cells between and within tissues, biomedical scientists have devised tools capable of simultaneously measuring dozens of characteristics of individual ...

New theory on genesis of osteoarthritis comes with successful therapy in mice

Scientists at Johns Hopkins have turned their view of osteoarthritis (OA) inside out. Literally. Instead of seeing the painful degenerative disease as a problem primarily of the cartilage that cushions joints, ...

Ginger compounds may be effective in treating asthma symptoms

Gourmands and foodies everywhere have long recognized ginger as a great way to add a little peppery zing to both sweet and savory dishes; now, a study from researchers at Columbia University shows purified components of the ...

'Gap' for HIV vaccine efforts after latest setback

The hunt for an HIV vaccine has gobbled up $8 billion in the past decade, and the failure of the most recent efficacy trial has delivered yet another setback to 26 years of efforts.